Dietary Rehabilitation in Severely Acutely Malnourished Children
NCT ID: NCT05009823
Last Updated: 2023-11-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1959 participants
OBSERVATIONAL
2021-08-10
2023-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The "Rehabilitation and Nutritional Education Center" (CREN) is a specialized center in Burkina Faso receiving on average 10 SAM children per day. Recovery rate is lower than international standards; and adverse events and mortality remain strikingly high.
The main objective of this study is to assess the underlying risk factors affecting the effectiveness of the nutritional therapeutic treatment protocol for complicated SAM children under 5 years of age who have been referred to the CREN, at the Centre Hôspitalier Universitaire Souro, Bobo Dioulasso, Burkina Faso.
The specific objective of this study is to better understand underlying risk factors associated with a lower recovery rate and high mortality in complicated SAM children referred to CREN for inpatient care. Risk factors associated with poor response to a standard dietary treatment at any phase will be assessed retrospectively.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Alternative Diets During the Stabilization Phase on Children With Complicated SAM
NCT05020847
Effectiveness of Four Transition Dietary Regimens in the Hospital Management of Children With Kwashiorkor.
NCT05015257
Effectiveness of an Alternative Protocol in the Management of Acute Malnutrition
NCT06792370
Alternative RUTFs for Treatment of Child Wasting
NCT06912620
Integrated Treatment Protocol for Acute Malnutrition: A Non Inferiority Trial in Burkina Faso
NCT03027505
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
For the treatment of SAM in hospital, the WHO recommends the use of therapeutic milk low in protein 'F75' in the stabilization phase; and more protein-rich F100 or F75 combined with ready-to-use therapeutic foods (RUTF) in the transition phase. The WHO also recommends using as an alternative formula made of cereal flour, skimmed milk powder, oil, sugar, and a therapeutic vitamin and mineral complex (CMV), in case of shortage of the standard therapeutic milk F75 / F100 or in case of signs of intolerance (vomiting, diarrhea).
The Refeeding Center - Centre de Récupération et d'Education Nutritionnelle (CREN) of the Sourô Sanou University Hospital Center (CHUSS) in Burkina Faso specializes in the care of SAM children with complications. In 2018, out of 500 children aged 6-59 months admitted for SAM with complications, the CHUSS CREN registered 86.8% full recovery, 8.2% dropout and 5% death. Although the recovery rate is higher than international standards (greater than 75%), the mortality rate remains higher than the recommended 3% by international standards; in addition to the challenges that are faced locally in maintaining high standards of care. At the CREN, the investigators and the nurses observed that some SAM children with complications can have severe diarrhea and vomiting after taking F75 (first phase of the nutritional treatment). It was also observed that other SAM children with edema, whose edema resolved in the first phase of treatment under F75, redeveloped edema when they received RUTF (Plumpy Nut®) in the transition phase according to the WHO 2013 protocol.
This research project, which will be subdivided into a retrospective study and two prospective clinical trials aims to assess the risk factors affecting the response to dietary treatment in this center (the CREN, Burkina Faso) and to compare alternatives for treatment during the nutritional rehabilitation.
The retrospective study assesses the factors of failure of dietary treatment in the three phases of nutritional rehabilitation to better understand underlying risk factors associated with a lower recovery rate and high mortality in complicated SAM children referred to CREN for inpatient care. Risk factors associated with poor response to a standard dietary treatment at any phase will be assessed retrospectively and include:
1. Errors in the treatment (feeding) dosage that can be due to errors in anthropometric measurement and/or in reading the feeding regimen table by the CREN team;
2. Low adherence of children to the therapeutic dietary regimen
3. Comorbidities associated with malnutrition that can have an effect on the dietary treatment effectiveness
4. Types of dietary regimen selected during the first phase of treatment \[F75 vs. alternative F75 (cereal flour, oil, sugar, powdered milk) with OR without CMV)\] and during the transition phase \[F75 + RUTF ( Plumpy-Nut®), F100, alternative F75 (with and without CMV) + RUTF (Plumpy Nut®)\].
The study will use data collected during admission and follow-up of SAM children with complications admitted at the CREN of the CHUSS from January 2014 to December 2018.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stabilization phase
The dietetic treatment is given by the nurses every 2 hours on the first day; then if tolerance is good, every 3 hours the following days. No family meals during the stabilization phase. But the baby can breastfeed.
A child will receive an antibiotic as per the national protocol, malaria treatment if diagnosed with malaria, Vitamin A if symptomatic eye damage, Folic acid in case of anemia, antifungal in case of candidiasis.
Standard F75
F-75 contains 75 kcal and 0.9 g protein per 100 ml.
Alternative F75 With CMV
Cereal flour, oil, sugar, powdered milk with complex mineral-vitamin.
Alternative F75 Without CMV
Cereal flour, oil, sugar, powdered milk without complex mineral-vitamin.
Transition phase
The child is assigned to one the therapeutic regimen depending on the treatment received during the stabilization phase and the results of the appetite test.
F100
100 kcal and 3 g protein per 100 ml if the test of appetite at the end of the stabilization phase is negative (the child does not accept the Plumpynut)
Standard F75 + RUTF
Standard F75 with ready to-use therapeutic food (Plumpynut) if the test of appetite at the end of the stabilization phase is positive
Alternative F75 with CMV + RUTF
Alternative F75 + CMV with ready to-use therapeutic food (Plumpynut) if the test of appetite at the end of the stabilization phase is positive and the child received Alternative F75 + CMV during the stabilization phase
Alternative F75 without CMV + RUTF
Alternative F75 - CMV with ready to-use therapeutic food (Plumpynut) if the test of appetite at the end of the stabilization phase is positive and the child received Alternative F75 - CMV during the stabilization phase
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Standard F75
F-75 contains 75 kcal and 0.9 g protein per 100 ml.
Alternative F75 With CMV
Cereal flour, oil, sugar, powdered milk with complex mineral-vitamin.
Alternative F75 Without CMV
Cereal flour, oil, sugar, powdered milk without complex mineral-vitamin.
F100
100 kcal and 3 g protein per 100 ml if the test of appetite at the end of the stabilization phase is negative (the child does not accept the Plumpynut)
Standard F75 + RUTF
Standard F75 with ready to-use therapeutic food (Plumpynut) if the test of appetite at the end of the stabilization phase is positive
Alternative F75 with CMV + RUTF
Alternative F75 + CMV with ready to-use therapeutic food (Plumpynut) if the test of appetite at the end of the stabilization phase is positive and the child received Alternative F75 + CMV during the stabilization phase
Alternative F75 without CMV + RUTF
Alternative F75 - CMV with ready to-use therapeutic food (Plumpynut) if the test of appetite at the end of the stabilization phase is positive and the child received Alternative F75 - CMV during the stabilization phase
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* With complications
* Who were admitted and treated in the refeeding center (CREN) of the CHUSS from January 2014 TO December 2018
* Aged between 0 and 59 Months
Exclusion Criteria
* Moderate Acute Malnutrition (MAM)
0 Months
59 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut de Recherche en Sciences de la Sante, Burkina Faso
OTHER_GOV
University Hospital Sourô Sanou of Bobo Dioulasso (Burkina Faso)
UNKNOWN
Centre Muraz
OTHER
University Ghent
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stefaan De Henauw, Md. PhD
Role: PRINCIPAL_INVESTIGATOR
University Ghent
Souheila Abbeddou, MSc. PhD
Role: PRINCIPAL_INVESTIGATOR
University Ghent
Jerome Some, Md. PhD
Role: PRINCIPAL_INVESTIGATOR
Institut de Recherche en Sciences de la Sante, Burkina Faso
Bintou Sanogo, MSc. Md.
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Universitaire Souro, Bobo Dioulasso, Burkina Faso.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Universitaire Souro
Bobo-Dioulasso, , Burkina Faso
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Baraki AG, Akalu TY, Wolde HF, Takele WW, Mamo WN, Derseh B, Desyibelew HD, Dadi AF. Time to recovery from severe acute malnutrition and its predictors: a multicentre retrospective follow-up study in Amhara region, north-west Ethiopia. BMJ Open. 2020 Feb 13;10(2):e034583. doi: 10.1136/bmjopen-2019-034583.
Bartz S, Mody A, Hornik C, Bain J, Muehlbauer M, Kiyimba T, Kiboneka E, Stevens R, Bartlett J, St Peter JV, Newgard CB, Freemark M. Severe acute malnutrition in childhood: hormonal and metabolic status at presentation, response to treatment, and predictors of mortality. J Clin Endocrinol Metab. 2014 Jun;99(6):2128-37. doi: 10.1210/jc.2013-4018. Epub 2014 Feb 27.
Deen JL, Funk M, Guevara VC, Saloojee H, Doe JY, Palmer A, Weber MW. Implementation of WHO guidelines on management of severe malnutrition in hospitals in Africa. Bull World Health Organ. 2003;81(4):237-43. Epub 2003 May 16.
Munthali T, Jacobs C, Sitali L, Dambe R, Michelo C. Mortality and morbidity patterns in under-five children with severe acute malnutrition (SAM) in Zambia: a five-year retrospective review of hospital-based records (2009-2013). Arch Public Health. 2015 May 1;73(1):23. doi: 10.1186/s13690-015-0072-1. eCollection 2015.
Related Links
Access external resources that provide additional context or updates about the study.
World Health Organization (2013) WHO guideline: updates on the management of severe acute malnutrition in infants and children.
Enquête Nutritionnelle Nationale SMART 2016 au Burkina Faso. 2016 ; 47p.
10\. Ministère de la Sante au Burkina Faso. Protocol National : Prise en charge intégrée de la malnutrition aigüe (PCIMA). 2014
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BC-09443
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.